← Leaderboards
Jamarius Waller
University Of Mississippi Med Ctr
$86,197
Attributed
$86,197
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $39.7K · FY2020–22$50K$37.5K$25K$12.5K$0
'20
'21
'22
Funding mix
By agency
NIH$86,197 · 1
By mechanism
F31$86,197 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Mississippi Med Ctr
Same institution · by research overlap
- Gene Leflore Bidwell$7,746,562
- Denise Creshun Cornelius$3,302,752
- Eric Matthew George$2,722,050
- Babbette Babbette Lamarca$4,995,735
- Frank Travis Spradley$1,649,606
Others in their field
Other Emerging Leaders on “Angiogenesis”
- Yi Tan · University Of Louisville$5,480,724
- Bradley David Gelfand · University Of Virginia$5,037,924
- Junjie Yao · Brigham And Women'S Hospital$4,736,402
- Ye Sun · Boston Children'S Hospital$4,181,435
- Sana D Karam · University Of Colorado Denver$4,039,397
- Jenny Huanjiao Zhou · Yale University$3,768,750
Research focus
AngiogenesisAffectAssociated SymptomAttenuatedAngiogenic FactorBiodistributionBiologicalBiopolymersBloodBlood CirculationBlood PressureBindingBlood Pressure ReductionBrain Hypoxia-IschemiaBurden Of IllnessCardiovascular Disorder RiskCareerCarrier ProteinsCell PhysiologyChildChimeric ProteinsChronicDisease OutcomeDoctor Of Medicine
Grant awards (3)
The use of a biopolymer-fused form of VEGF-B for the treatment of Preeclampsia.$7,331
F31 · FY2022 · HL · contact PI
The use of a biopolymer-fused form of VEGF-B for the treatment of Preeclampsia.$39,691
F31 · FY2021 · HL · contact PI
The use of a biopolymer-fused form of VEGF-B for the treatment of Preeclampsia.$39,175
F31 · FY2020 · HL · contact PI